Concepedia
Statistics
Publications
40
Citations
1.8K
H-Index
20
Active since
2008
Affiliations
Henan Cancer Hospital(Current)
Zhengzhou University
Chinese Academy of Medical Sciences & Peking Union Medical College
Institute of Hematology & Blood Diseases Hospital
Peking University
Keshu Zhou is an author at Henan Cancer Hospital specializing in medicine, cancer research, and pathology.
Top concepts
MedicineOncologyPathologyCancer ResearchImmunologyImmunotherapyRadiation OncologyPharmacotherapyHematologyCancer Therapy
Publications per year
2008–2024
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
Jennifer R. Brown, Barbara Eichhorst, Peter Hillmen et al. · New England Journal of Medicine · 2022 · 414 citations · Full text
Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase
Yuqin Song, Keshu Zhou, Dehui Zou et al. · Clinical Cancer Research · 2020 · 176 citations
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study
Yuqin Song, Keshu Zhou, Dehui Zou et al. · Blood · 2022 · 143 citations · Full text
Long-term Efficacy, Pathology, Pharmacotherapy +17
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study
Wei Xu, Shenmiao Yang, Keshu Zhou et al. · Journal of Hematology & Oncology · 2020 · 128 citations · Full text
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
Peter Hillmen, Barbara Eichhorst, Jennifer R. Brown et al. · Journal of Clinical Oncology · 2022 · 89 citations · Full text
1–5 of 40